The acute, the chronic and the news of HIV-related renal disease in Africa

Kidney International

Volumn 78, Issue 3, 2010, Pages 239-245

  Arendse, Craig G ^a   Wearne, Nicola ^a   Okpechi, Ikechi G ^a   Swanepoel, Charles R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

acute kidney injury; AIDS; chronic kidney disease; HIV nephropathy

Indexed keywords

ANTIRETROVIRUS AGENT; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ACUTE KIDNEY FAILURE; AFRICA; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEALTH CARE POLICY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE COMPLEX DISEASE; IMMUNE COMPLEX NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBERCULOSIS; MICROALBUMINURIA; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SHORT SURVEY; VIRUS LOAD;

EID: 77954760622     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.155     Document Type: Short Survey

References (43)

1. The Joint United Nations Programme on HIV/AIDS (UNAIDS. 2008 report on the global AIDS epidemic. 2008 (12 July 2009). Available at: http:// data.unaids.org/pub/GlobalReport/2008/JC1510-2008GlobalReport-en.zip.
2. Mayosi BM, Fisher AJ, Lalloo UG , et al. The burden of non-communicable diseases in South Africa. The Lancet 2009;374: 934-947.
3. Mulenga LB, Kruse G, Lakhi S , et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS 2008;22: 1821-1827.
4. Bagshaw SM. Short and long-term survival after acute kidney injury. Nephrol Dial Transplant 2008;23: 2126-2128.
5. Kellum JA. Acute kidney injury. Crit Care 2008;36(Suppl): S141-S145.
6. Bellomo R, Ronco C, Kellum JA , et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;4: 1364-8535.
7. Saraladevi N, Omar A, Mohamed BG. Epidemiology of acute kidney injury in Africa. Semin Nephrol 2008;28: 348-353.
8. Lamiere N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006;2: 364-377.
9. Valerie AL, Steenkamp V, Stewart MJ. Acute renal failure associated with the use of traditional folk remedies in South Africa. Ren fail 2005;1: 35-43.
10. Swanepoel CR, Blockman M, Talmud J. Nephrotoxins in Africa. In: De Broe ME and Porter GA (eds). Clinical Nephrotoxins. Renal injury from drugs and chemicals. 3rd edn Springer press: New York, 2008 pp 859-870.
11. Cohen C, Karstaedt A, Frean J , et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis 2005;41: 1631-1637.
12. Eastwood JB, Corbishley CM, Grange JM. Tuberculosis and the kidney. J Am Soc Nephrol 2001;12: 1307-1314.
13. Murray AN, Cassidy MJ, Templecamp C. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis. Nephron 1987;46: 373-376.
14. Yoshioka K, Satake N, Kasamatsu Y , et al. Rapidly progressive glomerulonephritis due to rifampicin therapy. Nephron 2002;90: 116-118.
15. Rao TK, Filippone EJ, Nicastri AD , et al. Associated focal and semental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984;310: 669-673.
16. Carbone L, D'Agati V, Cheng JT , et al. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 1989;87: 389-395.
17. Levin ML, Palella F, Shah S , et al. HIV associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis 2001; 37: E39.
18. US Renal Data System: USRDS 2005 Annual Data Report. 2005.
19. Gerntholtz TE, Goetsch SJW, Katz I. HIV- related nephropathy: A South African perspective. Kidney Int 2006;69: 1885-1891.
20. Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV positive patients with varying degrees of proteinuria in South Afria. Kidney Int 2006; 69: 2243-2250.
21. Wools-Kaloustian K, Gupta S, Muloma E , et al. Nephrol Dial Transplant 2007; 22: 2208-2212.
22. Bruggeman LA, Ross MD, Tanji N , et al. Renal epithelium is a previously unrecognised site of HIV-1 infection. J Am Soc Nephrol 2000; 11: 2079-2087.
23. D'Agati V, Suh JI, Carbone L , et al. Pathology of HIV-associated nephropathy. Kidney Int 1989;35: 1358-1370.
24. Winston JA, Bruggeman LA, Ross MD , et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001;344: 1979-1984.
25. Atta MG, Choi MJ, Longenecker JC , et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am J Med 2005;118: 1288.
26. Atta MG, Longenecker JC, Fine DM , et al. Sonography as a predictor of human immunodeficiency virus associated nephropathy. J Ultrasound Med 2004;23: 603-1510
27. Estrella M, Fine DM, Gallant JE , et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV infected patients. Clin Infect Dis 2006; 43: 377-380.
28. Wyatt CM, Morgello S, Katz-Malamed R , et al. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 2009; 75: 428-434.
29. Kopp JB, Smith MW, Nelson GW , et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008;40: 1175-1184.
30. Papeta N, Chan KT, Prakash S , et al. Susceptibility loci for murine HIV- associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest 2009;119: 1178-1188.
31. Taylor BS, Sibueszczyk ME, McCutchan FE , et al. The challenge of HIV-1 subtype diversity. N Engl J Med 2008;358: 1590-1602.
32. Lucas GM, Eustace JA, Sozio S , et al. Highly active antiretroviral therapy and the incidence of HIV-1 associated nephropathy; a 12-year cohort study. AIDS 2004;18: 541-546.
33. National Department of Health, South Africa. National Antiretroviral Treatment Guidelines. 1st ed DOH: Pretoria, 2004.
34. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006;70: 1107-1114.
35. Szczech La, Kalayjian R, Rodriguez R , et al. A cross-sectional, multi-center survey describing clinical practice patterns for HIV infected hemodialysis patients. Kidney Int 2003;63: 2295-2301.
36. Szczech LA, Gupta SK, Habash R , et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004;66: 1145-1152.
37. Dellow E, Unwin R, Miller R , et al. Protease inhibitor therapy for HIV infection: the effect on HIV-associated nephrotic syndrome. Nephrol Dial Transplant 1999;14: 744-747.
38. Stringer JS, Zulu I, Levy J , et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296: 782-793.
39. Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet 2006;367: 1870-1872.
40. Toure S, Kouadio B, Seyler C , et al. Rapid scaling-up of antiretroviral therapy in 10 000 adults in Cote D'Ivoire: two-year outcomes and determinants. AIDS 2008; 22: 873-882.
41. Peters PJ, Moore DM, Mermin J , et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 2008;74: 925-929.
42. Mail and Guardian online (2009) December 1st (http://www.mg.co.za/ article/2009-12-01-govt-steps-up-fight-against-aids).
43. Lawn SD, Harries AD, Anglaret X , et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008;22: 1897-1908.